The Cell DIVE scalable multiplexing platform allows researchers to select from over 350 rigorously validated antibodies to design their studies and a workflow to image 60+ biomarkers in a single tissue section. Cancer researchers can map normal and diseased tissue by cell type, biomarker profile, and specific features.
Leica Microsystems
Wetzlar, Germany
GET PRICING
Sponsored Recommendations
Sponsored Recommendations
Laser Assisted Wafer Slicing with 3DOF Motion Stages
Dec. 18, 2024
Free Space Optical Communication
Dec. 18, 2024
Voice your opinion!
Voice your opinion!